About This Event
HOW TO FIND THE VENUE
Join us for an evening of networking and breakthrough presentations on the frontier of neuroscience and brain-computer interfaces hosted by PsyMed Ventures and DataJoint.
Greg Kubin, General Partner, PsyMed Ventures
Deblina Sarkar PhD, Assistant Professor, @ MIT, Founder and Director of Nano-Cybernetic Biotrek research lab
Nathalie Gouailhardou, CEO and Founder, Neurode
Allison Waters PhD, Assistant Professor of Psychiatry and Neuroscience @ Icahn School of Medicine at Mount Sinai, Waters Lab @ Nash Family Center for Advanced Circuit Therapeutics
Jacob Robinson PhD, CEO and Founder, Motif Neurotech
John Nelson
Speakers
Greg Kubin
Investing in Frontier Brain Tech, PsyMed Ventures
presenterGreg Kubin serves as a General Partner at PsyMed Ventures, where he leads investments in frontier brain technologies and mental health innovations, focusing on early-stage companies that advance neuroscience and psychological treatments. With a background in venture capital and healthcare, Kubin has achieved notable success in identifying and funding transformative startups in the neurotech sector, including several that have progressed to clinical trials. His expertise lies in bridging finance with scientific advancements in brain health, emphasizing ethical AI applications in mental health diagnostics. Kubin also co-hosts the Business Trip podcast, where he discusses emerging trends in tech and investment, contributing to broader industry conversations on innovation in neurotechnology.
Debina Sarkar
Assistant Professor,, MIT Media Lab
presenterDeblina Sarkar is a trans-disciplinary innovator, initially trained in electrical engineering and physics and then, has traversed the realm of biology, driven by curiosity and belief that truly disruptive technologies can immerge at the interface of diverse research arenas. Her inventions include, among others, a 6-atom thick channel quantum-mechanical transistor overcoming fundamental power limitations, an ultra-sensitive label-free biosensor, technology revealing previously invisible biological nanostructures of brain and the first ultra-miniaturized antenna that operates inside a living cell in 3D environment.
Nathalie Gouailhardou
CEO and Founder, Neurode
presenterNathalie Gouailhardou is the CEO and Founder of Neurode, a company focused on developing wearable headsets for brain imaging and stimulation, with applications in treating conditions like ADHD. She brings expertise in neurotechnology and neuroscience, having led innovative projects in non-invasive brain interfaces. Gouailhardou's background includes founding Neurode to advance mental health solutions through hardware and software integration. Her achievements encompass securing funding for Neurode and contributing to research in wearable neurotech devices. This work highlights her dedication to improving brain health technologies.
Allison Waters
Assistant Professor of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai
presenterThe Waters Lab develops and tests innovative brain measures and electrical neuromodulation strategies to optimize neuropsychiatric care. Our aim is to supercharge rehabilitation efforts for individuals battling depression, OCD, and various neurological disorders. In both my research and clinical practice at Mount Sinai, I am dedicated to a future where psychotherapy and neurotechnology converge seamlessly. Biometric tools, advanced neurotech, psychedelics and cool gadgets are increasingly accessible to consumers; it is now critical that we identify the physiological signals that offer actionable insights to those seeking transformative change in their lives.
Jacob Robinson
CEO and Co-Founder, Motif Neurotech
presenterCo-Founder of Motif Neurotech, building therapeutic brain computer interfaces for mental health diseases. Professor in Electrical & Computer Engineering and Bioengineering at Rice University where his group develops miniature technologies to manipulate and monitor physiology and neural circuit activity.
Jon Nelson
Cofounder, Neurolive
presenterJohn Nelson serves as the President and CEO of Aerojet Rocketdyne Holdings, Inc., where he leads the development of advanced rocket propulsion systems for aerospace and defense applications. With over two decades of experience in the industry, he has held senior leadership roles at major aerospace companies, focusing on engineering and program management. Nelson is recognized for his contributions to key projects, including propulsion for NASA's Artemis program and U.S. Department of Defense initiatives. His expertise lies in rocket motors, missile defense, and space exploration technologies, making him a prominent figure in these fields.
